(Q86716406)

English

The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy

scientific article published on 05 May 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

The efficacy of triplet antiemetic therapy with 0.75 mg of palonosetron for chemotherapy-induced nausea and vomiting in lung cancer patients receiving highly emetogenic chemotherapy (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

(3aS)-palonosetron

1 reference

based on heuristic

inferred from title

author name string

Satoru Miura

1

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Satoshi Watanabe

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Kazuhiro Sato

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Masato Makino

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Osamu Kobayashi

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hiromi Miyao

6

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Akira Iwashima

7

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Masaaki Okajima

8

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Junta Tanaka

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hiroshi Tanaka

10

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hiroshi Kagamu

11

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Akira Yokoyama

12

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Ichiei Narita

13

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Hirohisa Yoshizawa

14

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

publication date

5 May 2013

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Supportive Care in Cancer

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

21

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

9

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

2575-2581

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

https://scigraph.springernature.com/pub.10.1007/s00520-013-1835-2

0 references

Palonosetron plus 3-day aprepitant and dexamethasone to prevent nausea and vomiting in patients receiving highly emetogenic chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Pharmacokinetic and safety evaluation of palonosetron, a 5-hydroxytryptamine-3 receptor antagonist, in U.S. and Japanese healthy subjects

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A systematic review and meta-analysis of intravenous palonosetron in the prevention of chemotherapy-induced nausea and vomiting in adults

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The antiemetic 5-HT3 receptor antagonist Palonosetron inhibits substance P-mediated responses in vitro and in vivo

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The oral neurokinin-1 antagonist aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a multinational, randomized, double-blind, placebo-controlled trial in patients receiving high-dose cisplatin--the Aprepitant Protocol 052 St

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Randomized, placebo-controlled, pilot study evaluating aprepitant single dose plus palonosetron and dexamethasone for the prevention of acute and delayed chemotherapy-induced nausea and vomiting

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Antiemetics: American Society of Clinical Oncology clinical practice guideline update

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palonosetron triggers 5-HT(3) receptor internalization and causes prolonged inhibition of receptor function

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Chemotherapy-induced nausea and vomiting in clinical practice: impact on patients' quality of life.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Comparison of an aprepitant regimen with a multiple-day ondansetron regimen, both with dexamethasone, for antiemetic efficacy in high-dose cisplatin treatment

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Guideline update for MASCC and ESMO in the prevention of chemotherapy- and radiotherapy-induced nausea and vomiting: results of the Perugia consensus conference

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Palonosetron plus dexamethasone versus granisetron plus dexamethasone for prevention of nausea and vomiting during chemotherapy: a double-blind, double-dummy, randomised, comparative phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Proposal for classifying the acute emetogenicity of cancer chemotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Olanzapine versus aprepitant for the prevention of chemotherapy-induced nausea and vomiting: a randomized phase III trial

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Addition of the neurokinin 1 receptor antagonist aprepitant to standard antiemetic therapy improves control of chemotherapy-induced nausea and vomiting. Results from a randomized, double-blind, placebo-controlled trial in Latin America

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II dose-ranging study of palonosetron in Japanese patients receiving moderately emetogenic chemotherapy, including anthracycline and cyclophosphamide-based chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Synergistic antiemetic interactions between serotonergic 5-HT3 and tachykininergic NK1-receptor antagonists in the least shrew (Cryptotis parva).

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

A phase II study of palonosetron combined with dexamethasone to prevent nausea and vomiting induced by highly emetogenic chemotherapy.

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Single dose of palonosetron plus dexamethasone to control nausea, vomiting and to warrant an adequate food intake in patients treated with highly emetogenic chemotherapy (HEC). Preliminary results

1 reference

https://pubmed.ncbi.nlm.nih.gov/23644992

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S00520-013-1835-2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:23644992%20AND%20SRC:MED&resulttype=core&format=json

29 February 2020

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q86716406&oldid=1511431863"